Skip to main content
logo
Exit
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.50
+0.14 (2.61%)
Sep 18, 2025, 2:25 PM EDT - Market open

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
297218358---
Market Cap Growth
-58.92%-39.13%----
Enterprise Value
17371523---
Last Close Price
5.366.5813.42---
PB Ratio
2.091.863.15---
P/TBV Ratio
2.151.863.15---
Debt / Equity Ratio
0.060.090.100.19--
Asset Turnover
---0.010.02-
Quick Ratio
4.215.327.055.3918.2442.10
Current Ratio
4.435.527.215.5818.3542.15
Return on Equity (ROE)
-75.32%-85.37%-71.54%-58.84%-65.27%-
Return on Assets (ROA)
-41.91%-46.11%-36.15%-32.33%-38.07%-
Return on Capital (ROIC)
-47.77%-52.48%-40.64%-35.18%-40.81%-
Earnings Yield
-38.44%-45.18%-18.57%---
FCF Yield
-32.07%-37.51%-16.67%---
Buyback Yield / Dilution
-80.52%-493.67%-228.42%-5.00%-7.72%-
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q